Invention Grant
US08765761B2 6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor
有权
6-(1H-吲唑-6-基)-N- {4- [2-甲基-1-(吗啉-4-基)丙-2-基]苯基}咪唑并[1,2-A]吡嗪-8 - 胺或其药学上可接受的盐作为syk抑制剂
- Patent Title: 6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor
- Patent Title (中): 6-(1H-吲唑-6-基)-N- {4- [2-甲基-1-(吗啉-4-基)丙-2-基]苯基}咪唑并[1,2-A]吡嗪-8 - 胺或其药学上可接受的盐作为syk抑制剂
-
Application No.: US13868967Application Date: 2013-04-23
-
Publication No.: US08765761B2Publication Date: 2014-07-01
- Inventor: Scott A. Mitchell , Kevin S. Currie
- Applicant: Gilead Connecticut, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Connecticut, Inc.
- Current Assignee: Gilead Connecticut, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Morrison & Foerster LLP
- Main IPC: A61K31/495
- IPC: A61K31/495
![6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor](/abs-image/US/2014/07/01/US08765761B2/abs.jpg.150x150.jpg)
Abstract:
An imidazopyrazine having the structure or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.
Public/Granted literature
- US20130237520A1 IMIDAZOPYRAZINE SYK INHIBITORS Public/Granted day:2013-09-12
Information query